Biologically active substances 'differ in hepatitis E patients'
Feb 07 2011
A team writing in Proteome Science explain how they used mass spectrometry to enrich the peptidome fraction of subjects' plasma.
They were able to identify a number of biologically active substances associated with immune response that were differentially expressed between the infected and control groups.
In turn, they have created a peptide profile they say could be useful in future diagnoses of hepatitis E.
The condition occurs when contaminated drinking water is consumed, according to guidance from the World Health Organization.
However, it is not known to commonly be caused by person-to-person contact, during sex or during blood transfusions.
Moreover, the condition is self-limiting and typically clears up, except in acute cases where fulminant hepatic failure may occur and no known course of treatment exists to alter the outcome.
In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Oct 10 2023 Hybrid event
Oct 15 2023 Katowice, Poland
Nov 05 2023 Vienna, Austria
Nov 12 2023 Louisville, KY, USA
Nov 13 2023 Plainsboro, NJ, USA